The pharmacy giant has been among the rumored bidders for the primary care disruptor, with Humana said to be another suitor. Humana does have a right-of-refusal deal with Cano Health in the event of a sale, under a 2019 agreement between the two entities.
People familiar with the matter also told Bloomberg that CVS is conducting due diligence on Cano Health, which aims its primary care services at seniors. CVS and Cano both declined to comment to the news outlet.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
